Latest reported quarter: ANNUAL, ended Dec 2025
Quarter 2026/Q2
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| Net Non-Operating Interest Income (Expense) | -$28.70M | -$65.30M | -$78.20M | -$39.21M | -$18.50M |
| Other Income (Expense) | -$1.20M | $300,000.00 | -$3.00M | $23.19M | -$16.20M |
| Non-Operating Interest Expense | $28.70M | $65.30M | $78.20M | $39.21M | $18.50M |
| Operating Profit | $413.90M | $319.90M | $258.80M | $175.31M | $186.55M |
| Selling and Admin Expenses | $399.20M | $383.30M | $328.70M | $281.58M | $230.11M |
| Operating Expense | $399.20M | $383.30M | $328.70M | $281.58M | $230.11M |
| Gross Profit | $813.10M | $703.20M | $587.50M | $456.89M | $416.66M |
| Cost of Revenue | $6.76B | $5.66B | $5.13B | $3.96B | $3.08B |
| Total Operating Revenue | $7.57B | $6.37B | $5.72B | $4.42B | $3.50B |
| Total Revenue as Reported | $7.57B | $6.37B | $5.72B | $4.42B | $3.50B |
| Dividend Per Share | $0.32 | $0.26 | $0.24 | $0.24 | $0.24 |
| Gain on Sale of Security | -$100,000.00 | $2.70M | $1.10M | $1.09M | -$95,000.00 |
| Special Income (Charges) | -$2.40M | -$2.50M | -$5.70M | $20.03M | -$16.40M |
| Diluted EPS | $5.02 | $3.31 | $2.33 | $2.47 | $2.17 |
| Basic EPS | $5.09 | $3.37 | $2.37 | $2.50 | $2.19 |
| Net Income to Common Stockholders | $274.90M | $180.90M | $126.10M | $133.02M | $115.74M |
| Net Income to Parent Company | $274.90M | $180.90M | $126.10M | $133.02M | $115.74M |
| Profit from Continuing Operations | $274.90M | $180.90M | $126.10M | $133.02M | $115.74M |
| Net Profit | $274.90M | $180.90M | $126.10M | $133.02M | $115.74M |
| Tax | $109.10M | $74.00M | $51.50M | $26.27M | $36.12M |
| Pretax Profit | $384.00M | $254.90M | $177.60M | $159.29M | $151.86M |
| Other Non-Operating Income (Expenses) | $1.30M | $100,000.00 | $1.60M | $2.07M | $299,000.00 |
| -Less:Restructuring and Mergern & Acquisition | $2.40M | $2.50M | $5.70M | $20.05M | $16.40M |
| -Gain on Sale of Property/Plant/Equipment | – | – | – | $40.08M | $0.00 |
No comments yet — be the first to weigh in on PRIM.